Walleye Trading
MCRB icon

Walleye Trading’s Seres Therapeutics MCRB Stock Holding History

Walleye Trading’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-45
Closed -$5.1K – 4968
2023
Q1 		$5.1K Hold
45
– – ﹤0.01% 4493
2022
Q4 		$5.04K Buy
+45
New +$6.03K ﹤0.01% 4594
2021
Q4 		– Sell
-270
Closed -$38K – 5646
2021
Q3 		$38K Sell
270
-260
-49% -$50.9K ﹤0.01% 4721
2021
Q2 		$253K Buy
+530
New +$224K ﹤0.01% 3691
2020
Q4 		– Sell
-5
Closed -$3K – 4799
2020
Q3 		$3K Buy
+5
New +$1.66K ﹤0.01% 3991

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Trading's MCRB Position: Q4 2023 in Review

Walleye Trading sold out of Seres Therapeutics (MCRB) in Q4 2023, closing a stake of 753 shares — an estimated $35.8K sold.

Walleye Trading first reported a position in MCRB in Q3 2018 and held it in 8 quarters. The position peaked at $1.32M in Q3 2020. 102 funds tracked by Wall St. Rank hold MCRB as of Q4 2023.

  • Walleye Trading reported no remaining Seres Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Walleye Trading sold 753 Seres Therapeutics shares in Q4 2023, an estimated $35.8K.
  • Walleye Trading first reported a position in Seres Therapeutics in Q3 2018 and held it in 8 quarters.
  • Walleye Trading's Seres Therapeutics position peaked at $1.32M in Q3 2020.
  • 102 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2023.

Based on Walleye Trading's 13F filing for Q4 2023, filed 14 Feb 2024.